 |
|
|
|||||
Gland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 crore, with margins improving by 300 basis points to 26%. R&D expenses were Rs 43.7 crore, making up 4.3% of the revenue.
Category:
News and Media
Gold prices remain near record highs as investors worry about potential inflation due to President Trump's tariffs on Canada, China, and Mexico. Trump has suspended tariffs on Mexico and Canada for 30 days, while tariffs on Chinese goods proceed. Economic data later in the week will offer further insight into the economy's strength.
Category:
News and Media
Dr Agarwal's Health Care's upcoming listing worries investors due to a discounted grey market premium and muted subscription. Despite being India's largest eye care chain, with a 25% market share in FY24, and significant revenue and efficiency growth, market conditions appear challenging. Analysts recommend a long-term investment view for potential gains.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||